Myeloid derived suppressor cells: Targets for therapy. - Wikidata - awgldk - TriplyDB

Myeloid derived suppressor cells: Targets for therapy.

Myeloid derived suppressor cells: Targets for therapy.

http://www.wikidata.org/entity/Q36845851

about

Myeloid-Derived Suppressor Cells in Bacterial Infections Trial watch: IDO inhibitors in cancer therapy Trial watch: Dendritic cell-based anticancer therapy Trial Watch-Oncolytic viruses and cancer therapy The tumor microenvironment in esophageal cancer Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy Trial Watch: Toll-like receptor agonists in oncological indications.Trial Watch: Peptide-based anticancer vaccines.Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer.The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis.Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy.Squamous Cell Cancers: A Unified Perspective on Biology and Genetics Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses.Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche.Myeloid-derived suppressor cells as effectors of immune suppression in cancer.Unleashing the immune response against childhood solid cancers.GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro.The clinical and prognostic significance of CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy.Deficiency of Kruppel-like factor KLF4 in myeloid-derived suppressor cells inhibits tumor pulmonary metastasis in mice accompanied by decreased fibrocytes.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.Trial Watch: Lenalidomide-based immunochemotherapy.Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells.Trial Watch: Radioimmunotherapy for oncological indications.Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients.CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients.Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.

P2860

Q26749373-26F17309-1BEE-4395-9943-95170FBE573C Q27006866-B318F080-2FF6-41CB-9FED-023A9618DCDF Q27024047-2E2147A4-3E01-4D1F-8126-73966ED656F4 Q28072347-5DD6CADD-9AE6-486B-9BFD-C898BDB49608 Q28077074-70DE3DE7-97CA-4556-9A7A-FC3F5FAB70C5 Q28082461-5F6C8F2C-FF77-473C-901F-884A3964FDD2 Q33878578-9D4A893A-42B1-4656-A12F-634A4E158A3B Q34483345-BFEAEE43-7B99-437C-97BD-0E0D72DA0A79 Q36060333-ADEF2443-9C88-4490-9374-561A5104C80E Q36118086-400F4936-8A5A-44ED-B8A1-F3D925FC383E Q36174161-BD173E97-BC25-496D-9498-4BCCCCDDAF26 Q36796146-B7DD74EE-879D-4514-8374-528B2DD62797 Q36909843-C8D46EBC-57AC-4639-AB71-43C457601AA4 Q37644986-B0A8F32D-33B5-4E91-948E-3B0662A5EB95 Q38185156-9475B050-3681-46FF-A0D8-0042893B3EE3 Q38232436-F7F92945-5472-4C66-BB34-2E51245B073D Q38864758-FB838F59-573A-4A2E-A2B4-6EAF487DFE41 Q39224315-3562BDD0-1B7E-4427-B435-8ADCED980C58 Q40032613-1A53B255-2007-4155-83AA-95C370E8F7A1 Q40929576-43C0E03C-40EC-4D3D-A450-1DA33BA357A0 Q42536239-F595787C-82CB-4EC7-B3D6-A48CF7F3C554 Q42702234-933E4585-2E06-4339-84FA-B8918AF81BCE Q42737828-C1C11E33-5DA9-44AF-8BD7-68111913BE4C Q42840029-549CF953-2C28-46A9-B720-E2BDBD52D089 Q43104064-A6C33DE1-9103-4A5C-8EEC-1EFE48980692 Q47146426-4BA20FE3-7D9D-4776-998A-FD2860CFC374 Q48223884-077B92A4-BF7B-4B13-A478-6184D801BD38 Q52644017-17B9BC26-5FE0-48AB-9FA2-9DF5BE2BF5AB Q52758913-370931BB-E944-4ADB-9172-0EF3764322E0

P2860

Myeloid derived suppressor cells: Targets for therapy.

http://www.wikidata.org/entity/Q36845851

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Myeloid derived suppressor cells: Targets for therapy.

@en

type

label

Myeloid derived suppressor cells: Targets for therapy.

@en

prefLabel

Myeloid derived suppressor cells: Targets for therapy.

@en

P1433

Q36845851-0B247429-0E15-49B2-B133-322D9DB580DA

P1476

Q36845851-0B920FC7-2EBF-4401-B64F-7B1D0E78E4B4

P2093

Q36845851-0C139627-1989-485D-8807-4B5C085FE569

Q36845851-1447BC76-C262-4924-A6C4-60B266C06E41

Q36845851-7020097E-F0E6-4A7F-B96E-ACA4AF9D5979

Q36845851-8F7BBA3A-57B4-4829-9C66-BF2CAF5E56F9

Q36845851-E4822F91-72E9-4476-9038-4F9F0E97C083

P2860

Q36845851-03EBD2A0-238C-436F-B688-7041CC7A128B

Q36845851-040A52EA-687A-464C-9F39-DADE2794C8A7

Q36845851-05AB99CA-F76A-42D7-B090-53C9442B12FC

Q36845851-0A24663D-A4A1-4746-8C32-A29B95ED0E5F

Q36845851-0F9653C9-9F9C-439B-9446-AC8DEDC54DD7

Q36845851-113EE2A3-4E7B-4757-8F57-896B625CC868

Q36845851-1E4D3B1F-BE8E-4DB7-A570-20D7D1C64224

Q36845851-1FDCFB2A-68B1-4F8C-85C8-B0AC8DC59BE5

Q36845851-2B3E5A09-9732-434C-9D52-15414A941CC5

Q36845851-2C747D58-7ACF-46DF-8F18-305D0FBEFFAD

P304

Q36845851-D74FF885-C7FB-40ED-9278-D67F714F785F

P31

Q36845851-0BCBE967-7F53-46F7-A404-CDDAD1B33F3C

P356

Q36845851-83C38E5D-C1D9-4D75-B4B5-7732D09D2EED

P433

Q36845851-EA000D50-19E8-4F03-BFF9-7AD44D159767

P478

Q36845851-BCC0788B-B61F-465A-AFCE-685FA3A663CE

P577

Q36845851-8D5C902D-6347-459A-80B5-707CB80FAEE3

P5875

Q36845851-B5C9238C-6DFC-4E66-A05D-0B031A215D91

P698

Q36845851-3F21E291-A553-4EE9-AACD-42036B0B2FB5

P932

Q36845851-8DE5931A-2B01-46CB-BE31-90165F97CD60

P356

P1433

P1476

Myeloid derived suppressor cells: Targets for therapy.

@en

P2093

Anil K Rustgi

http://www.w3.org/2001/XMLSchema#string

Jon G Quatromoni

http://www.w3.org/2001/XMLSchema#string

Sunil Singhal

http://www.w3.org/2001/XMLSchema#string

Tatiana A Karakasheva

http://www.w3.org/2001/XMLSchema#string

Todd J Waldron

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunotherapy: moving beyond current vaccines

Modes of resistance to anti-angiogenic therapy

Myeloid-derived suppressor cells: linking inflammation and cancer

Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.

Myeloid suppressor cells and immune modulation in lung cancer

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Myeloid-derived suppressor cells as regulators of the immune system

Cancer immunoediting: from immunosurveillance to tumor escape

Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

P304

e24117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.24117

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237018436

http://www.w3.org/2001/XMLSchema#string

P698

23734336

http://www.w3.org/2001/XMLSchema#string

P932

3654606

http://www.w3.org/2001/XMLSchema#string